Skip to content
HowShorted

SPRUCE BIOSCIENCES, INC. short interest in 2021

In 2021, SPRUCE BIOSCIENCES, INC.'s disclosed short interest ran from 1.71% of shares outstanding on 15 Jan 2021 to 5.18% on 31 Dec 2021, a change of +3.47 percentage points. The year's high was 5.18% on 31 Dec 2021 and its low 1.63% on 12 Feb 2021, averaging 2.16% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.10 days on 29 Jan 2021. Full history: SPRUCE BIOSCIENCES, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SPRUCE BIOSCIENCES, INC. in 2021

2021 in figures

Start of year
1.71% (15 Jan 2021)
End of year
5.18% (31 Dec 2021)
Change
+3.47 pp
High
5.18% (31 Dec 2021)
Low
1.63% (12 Feb 2021)
Average
2.16%
Highest days to cover
18.10 (29 Jan 2021)
SEC filings marked
9

Every report in 2021

SPRUCE BIOSCIENCES, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20211.71%8.33results (8-K)
29 Jan 20211.65%18.10
12 Feb 20211.63%11.12
26 Feb 20211.68%17.16
15 Mar 20211.69%9.10
31 Mar 20211.84%6.4910-K filed, results (8-K)
15 Apr 20212.02%14.49
30 Apr 20211.92%4.92
14 May 20211.99%6.7810-Q filed, results (8-K)
28 May 20211.95%7.44
15 Jun 20212.07%11.47
30 Jun 20212.19%3.81
15 Jul 20212.12%10.29
30 Jul 20212.09%8.14
13 Aug 20212.27%13.3410-Q filed, results (8-K)
31 Aug 20212.29%13.01
15 Sep 20212.32%14.88
30 Sep 20212.07%11.38
15 Oct 20212.01%9.38
29 Oct 20212.05%3.89
15 Nov 20212.03%4.5910-Q filed, results (8-K)
30 Nov 20212.25%1.43
15 Dec 20212.89%1.20
31 Dec 20215.18%1.00

See also: SPRUCE BIOSCIENCES, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.